Cornell Center for Social Sciences names spring grantees

New grants from the Cornell Center for Social Sciences (CCSS) will fund research ranging from exploring why people spread polarizing content online to assessing health care access in rural New York.

Around Cornell

Integrating STEM majors won’t end gender segregation at work

Increasing women’s representation in science, technology, engineering and math majors will reduce – but not nearly eliminate – gender disparities in STEM occupations, new Cornell sociology research finds.

Upcycling method turns textile trash to functional coatings

To make textiles more sustainable, a new method allows researchers to break old clothing down chemically and reuse polyester compounds to create fire resistant, anti-bacterial or wrinkle-free coatings that could then be applied to clothes and fabrics.

Mars Rover documentary to screen at Cornell Cinema

Cornell Cinema will present a free screening of the documentary Good Night Oppy May 2.

Around Cornell

Arts and Sciences faculty featured on Academic Minute

Five faculty from the College of Arts and Sciences will be featured on a “Cornell week” on The Academic Minute radio program from May 1-5.

Around Cornell

Incubator to support projects for work and social change

The Yang-Tan WorkABILITY Incubator, recently launched through the ILR School’s Center for Applied Research on Work, will support innovative applied research projects and collaborations.

Racial equity messaging must be more inclusive

In a review of more than three decades’ worth of studies a Cornell-led research group found that more research on messaging that includes the voices of historically marginalized people is necessary in the push toward equity.

New research sheds light on how circadian rhythms work

New research from a multidisciplinary team helps to illuminate the mechanisms behind circadian rhythms, offering new hope for dealing with jet lag, insomnia and other sleep disorders.

Interfering with antiviral pathway may deter Alzheimer’s

Targeting part of a key antiviral pathway may one day offer a new therapeutic approach to deterring or delaying cognitive decline, according to preclinical research led by Weill Cornell Medicine scientists.